Viking Therapeutics Overview
Viking Therapeutics Target Price
Analysts' 12-month price predictions for VKTX.
Share Price
$28.14
Average Target Price
$75.00
166.5% upside
166.5% upside1 analysts in the last 4 months
High: $75 | Low: $75
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-04-28 | Truist FinancialJoon Lee | $75 | 166.5% upside |  |
| 2024-12-02 | Piper SandlerBiren Amin | $74 | 163% upside | |
| 2024-11-04 | LaidlawYale Jen | $110 | 290.9% upside | |
| 2024-11-04 | JefferiesRoger Song | $110 | 290.9% upside | |
| 2024-06-27 | Morgan StanleyMichael Ulz | $105 | 273.1% upside | |
| 2024-06-25 | H.C. WainwrightJoseph Pantginis | $90 | 219.8% upside | |
| 2024-05-16 | Raymond JamesSteve Seedhouse | $116 | 312.2% upside | |
| 2024-05-16 | Truist FinancialJoon Lee | $120 | 326.4% upside | |
| 2024-03-26 | OppenheimerJay Olson | $138 | 390.4% upside | |
| 2024-03-26 | BTIGJustin Zelin | $125 | 344.2% upside | |
| 2024-03-26 | Stifel NicolausSamimy Annabel | $95 | 237.6% upside | |
| 2024-03-15 | BTIGJustin Zelin | $100 | 255.4% upside | |
| 2022-12-24 | Maxim GroupMaxim Maxim | $15 |  46.7% downside | |
| 2022-12-19 | BTIGJustin Zelin | $20 | 28.9% downside | |
| 2022-12-19 | H.C. WainwrightJoseph Pantginis | $21 | 25.4% downside | |